Third-Party Tested ≥98% HPLC Purity — USA Shipped

Retatrutide 20mg - Research Peptide
Metabolic & Incretin 20mg

Retatrutide 20mg

$140.00 In Stock

Triple-agonist research peptide targeting GIP, GLP-1, and glucagon receptors for advanced metabolic studies.

$140.00
1
≥98%
HPLC Purity
COA
Included
USA
Based Supplier

Description

Triple-agonist research peptide targeting GIP, GLP-1, and glucagon receptors for advanced metabolic studies.

Retatrutide is a first-in-class triple-agonist peptide that simultaneously activates glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1), and glucagon receptors. Its mechanism of action involves binding all three receptor systems to modulate appetite signaling, glucose homeostasis, and energy expenditure through complementary metabolic pathways. The glucagon receptor component is believed to contribute additional energy expenditure and hepatic lipid metabolism benefits not seen with GLP-1-only or GIP/GLP-1 dual agonists. Compared to semaglutide (GLP-1 only) and tirzepatide (GIP/GLP-1 dual), retatrutide represents an expansion of the incretin-based approach by incorporating glucagon receptor activation, which studies suggest modulates thermogenesis and fat oxidation. For research use, the lyophilized powder should be stored at -20C and reconstituted with bacteriostatic water immediately before use; reconstituted solutions remain stable under refrigeration at 2-8C for up to 28 days. This compound is primarily investigated by academic metabolic research centers, pharmaceutical R&D divisions, and endocrinology laboratories studying multi-receptor agonism as a strategy for metabolic syndrome research.

This product is supplied as a lyophilized powder and is intended for laboratory and research use only. Not for human consumption. Each vial contains 20mg of research-grade material.

Read the full Retatrutide research guide

Research Applications

  • GIP/GLP-1/Glucagon receptor agonist research
  • Metabolic-pathway research
  • Glucose regulation and insulin sensitivity
  • Metabolic and GH-axis research

Specifications

Size
20mg
Purity
≥98% (HPLC)
Form
Lyophilized Powder
Molecular Formula
C223H343F3N46O70
Molecular Weight
4731.33 g/mol
CAS Number
2381089-83-2
Sequence
YA1QGTFTSDYSIL2LDKK4AQA1AFIEYLLEGGPSSGAPPPS3

Storage & Handling

  • Long-term storage: -20°C in a sealed, light-protected container
  • Short-term storage: 2-8°C (refrigerated) for up to 30 days
  • Reconstituted: Store at 2-8°C and use within 30 days
  • Avoid: Repeated freeze-thaw cycles, direct sunlight, and moisture exposure
  • Reconstitution: Use bacteriostatic water or sterile water for injection

Frequently Asked Questions

What is GLP3-R (Retatrutide) and how does it work?
Retatrutide is a triple-agonist peptide that simultaneously targets GIP, GLP-1, and glucagon receptors. Unlike single- or dual-agonist compounds, retatrutide activates all three incretin and glucagon pathways, which in preclinical models has been observed to influence glucose homeostasis, energy expenditure, and lipid metabolism through complementary mechanisms. This tri-receptor engagement represents a novel approach in metabolic research.
What research has been done on GLP3-R (Retatrutide)?
Preclinical studies have also explored its effects on hepatic lipid content, with researchers observing reductions in liver fat in animal models. Additional investigations are examining its potential role in non-alcoholic steatohepatitis (NASH) and cardiovascular biomarkers.
How does Retatrutide compare to Semaglutide or Tirzepatide?
While semaglutide acts solely on the GLP-1 receptor and tirzepatide targets both GIP and GLP-1 receptors, retatrutide adds a third mechanism through glucagon receptor agonism. In research settings, this triple-agonist approach has been associated with greater effects on energy expenditure and lipid oxidation compared to single- or dual-agonist peptides. Each compound occupies a distinct pharmacological profile for comparative metabolic research.

Related Products

5-Amino-1MQ 5mg
5mg In Stock

5-Amino-1MQ

NNMT modulator for metabolic and metabolic-pathway research.

$37.50
Tesamorelin 5mg
5mg In Stock

Tesamorelin

Synthetic GHRH analogue studied for visceral fat reduction and metabolic health.

$40.50
AOD-9604 5mg
5mg In Stock

AOD-9604

Synthetic hGH fragment 176-191 analogue for lipid metabolism research.

$44.00

Research Use Only. This product is not intended for human consumption, therapeutic use, or diagnostic purposes. All peptides sold by Elyte Peptides are strictly for in-vitro research and laboratory use. By purchasing, you agree to use this product in compliance with all applicable laws and regulations.